CRN04777 Given Rare Pediatric Disease Designation for Congenital Hyperinsulinism
source: pixabay.com

CRN04777 Given Rare Pediatric Disease Designation for Congenital Hyperinsulinism

  In a recent press release, clinical-stage pharmaceutical company Crinetics Pharmaceuticals announced that their investigational drug candidate, CRN04777, received Rare Pediatric Disease designation from the FDA. The therapy is designed…

Continue Reading CRN04777 Given Rare Pediatric Disease Designation for Congenital Hyperinsulinism